Today: 3 May 2026
UiPath stock set for Jan. 2 open after CEO share sale, S&P MidCap 400 entry looms (PATH)
2 January 2026
2 mins read

UiPath stock set for Jan. 2 open after CEO share sale, S&P MidCap 400 entry looms (PATH)

NEW YORK, January 1, 2026, 20:45 ET — Market closed.

  • UiPath shares last closed at $16.39, down 1.7%, in the most recent session on Dec. 31.
  • A filing showed CEO Daniel Dines sold 90,000 shares for about $1.5 million under a pre-set trading plan.
  • UiPath is slated to join the S&P MidCap 400 before Friday’s open, a shift that can drive index-fund rebalancing flows.

UiPath Inc. shares ended the last trading day of 2025 down 1.7% at $16.39, after a regulatory filing showed Chief Executive Daniel Dines sold another block of stock. The shares were last at $16.34 in after-hours trading.

U.S. stock markets were shut on Thursday for the New Year’s Day holiday and reopen on Friday, putting the focus on how the stock trades when normal liquidity returns.

The timing is sensitive because UiPath is scheduled to join the S&P MidCap 400 before Friday’s opening bell, replacing Synovus Financial as Pinnacle Financial Partners moves to acquire it, S&P Dow Jones Indices said. In plain English, funds that mirror the index may need to buy UiPath shares to match the benchmark, which can create one-off demand around the rebalance.

A Form 4 filing showed Dines sold 45,000 shares on Dec. 30 and another 45,000 shares on Dec. 31, for total proceeds of about $1.5 million. The filing said the trades were executed under a Rule 10b5-1 plan, a pre-arranged program that lets executives trade on a set schedule.

Dines directly held 28.48 million shares after the transactions, the filing showed, and reported another 9.62 million shares held indirectly through Ice Vulcan Holding.

The stock has churned since a late-December pop tied to the index move, and Wednesday’s session drew heavy volume of about 69.6 million shares. Traders often view that mix—big volume and a lower close—as a sign of positioning ahead of a known catalyst.

Investors are also stepping into 2026 focused on artificial-intelligence spending and the path of U.S. interest rates—two forces that can swing valuations for software companies like UiPath. “For another year of strong double-digit percentage returns, markets need everything firing on all cylinders,” said Sam Stovall, chief investment strategist at CFRA. Reuters

UiPath sells enterprise automation software that helps businesses run repetitive digital tasks—often called robotic process automation, or RPA—alongside newer AI-driven workflows.

For UiPath traders, Friday’s open will test whether index-related buying can offset the negative signal some investors take from insider sales, even when they are pre-planned and disclosed after the fact.

Before the next session, attention will be on the opening auction and any outsized imbalance tied to the MidCap 400 rebalance. A return to the $17 area would suggest the index effect is dominating the tape, while sustained trade around the mid-$16 range would signal investors are leaning more heavily on the insider-selling headline.

UiPath’s investor relations calendar lists no upcoming events, leaving the next firm-specific catalyst as the company’s next earnings date and any update to guidance.

On the macro side, traders are bracing for a run of U.S. data next week, including the December employment report on Jan. 9 and inflation data the following week—prints that can move rate expectations and, by extension, high-growth software stocks.

Stock Market Today

  • Is Singapore Exchange (SGX:S68) Overvalued After 55% Rally?
    May 3, 2026, 7:46 AM EDT. Singapore Exchange (SGX:S68) has surged 55.1% over the past year, with a 27.3% gain year-to-date. Despite this strong price performance, valuation models suggest caution. The company's Excess Returns model indicates the stock is approximately 30% overvalued at around SGD21.70, based on intrinsic value estimates of SGD16.64. Other valuation metrics, including Price-to-Earnings (P/E) ratios and discounted cash flow approaches, point to similar concerns. Investors should weigh these assessments carefully against the exchange operator's role in Singapore's capital markets amid changing trading volumes, product mix, and regulatory shifts. The stock holds a zero score on key valuation checks, raising questions about its future valuation potential.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 03.05.2026

3 May 2026
Rivian shares fell 8.4% to $15.02 after first-quarter results beat expectations, as investors focused on cash burn and profitability concerns. Trading volume jumped 78% above average. The company plans to ramp up R2 SUV production in Georgia to 300,000 units annually. Tesla and Lucid Group shares both rose more than 2%.
Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

3 May 2026
Vertiv shares hit a 52-week high Friday before closing at $328.31, following a 30% jump in Q1 net sales to $2.65 billion. The company raised its 2026 outlook and recently acquired Strategic Thermal Labs, expanding its liquid cooling portfolio. Investors await further details at Vertiv’s May 19-20 conference in South Carolina.
AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

3 May 2026
AT&T closed a $6 billion sale of long-dated notes on April 30, with maturities ranging from 2033 to 2066, according to an SEC filing. The company reported first-quarter free cash flow of $2.5 billion, down from $3.1 billion a year earlier, citing higher capital investment. AT&T is preparing to close a $23 billion purchase of EchoStar spectrum licenses. CFO Pascal Desroches said net debt to adjusted EBITDA rose to 2.71 times.
Ford stock closes 2025 at $13.12 as Wall Street slips; what investors watch next for NYSE:F
Previous Story

Ford stock closes 2025 at $13.12 as Wall Street slips; what investors watch next for NYSE:F

Cytokinetics (CYTK) stock closes up 3.5% into year-end as Myqorzo launch nears, insider sale disclosed
Next Story

Cytokinetics (CYTK) stock closes up 3.5% into year-end as Myqorzo launch nears, insider sale disclosed

Go toTop